Tus Pharmaceutical Group Co Ltd (000590) — Cash Flow-to-Debt Ratio
Tus Pharmaceutical Group Co Ltd (000590) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥2.24 Million could theoretically repay 0% of its total liabilities (CN¥359.74 Million) in one year. See Tus Pharmaceutical Group Co Ltd (000590) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Tus Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Tus Pharmaceutical Group Co Ltd across 28 annual periods. For the full cash flow conversion analysis, see 000590 cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Tus Pharmaceutical Group Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Tus Pharmaceutical Group Co Ltd. Check cash flow quality index of Tus Pharmaceutical Group Co Ltd to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | CN¥28.96 Million | CN¥339.98 Million | ▲ +101.9% |
| 2024 | 0.04x | CN¥17.39 Million | CN¥412.18 Million | ▲ +162.8% |
| 2023 | -0.07x | CN¥-28.39 Million | CN¥422.92 Million | ▼ -157.2% |
| 2022 | 0.12x | CN¥54.47 Million | CN¥464.26 Million | ▲ +33.0% |
| 2021 | 0.09x | CN¥25.20 Million | CN¥285.50 Million | ▼ -57.6% |
| 2020 | 0.21x | CN¥51.48 Million | CN¥247.27 Million | ▲ +60.1% |
| 2019 | 0.13x | CN¥29.21 Million | CN¥224.58 Million | ▲ +4608.9% |
| 2018 | 0.00x | CN¥654.24K | CN¥236.88 Million | ▲ +100.9% |
| 2017 | -0.31x | CN¥-89.14 Million | CN¥290.40 Million | ▼ -246.2% |
| 2016 | -0.09x | CN¥-32.51 Million | CN¥366.72 Million | ▲ +44.1% |
| 2015 | -0.16x | CN¥-60.56 Million | CN¥381.64 Million | ▼ -25.5% |
| 2014 | -0.13x | CN¥-50.91 Million | CN¥402.71 Million | ▼ -968.0% |
| 2013 | 0.01x | CN¥4.12 Million | CN¥283.05 Million | ▼ -83.4% |
| 2012 | 0.09x | CN¥19.75 Million | CN¥225.44 Million | ▼ -28.6% |
| 2011 | 0.12x | CN¥30.87 Million | CN¥251.62 Million | ▼ -58.2% |
| 2010 | 0.29x | CN¥84.98 Million | CN¥289.85 Million | ▲ +144.8% |
| 2009 | 0.12x | CN¥34.14 Million | CN¥285.11 Million | ▼ -14.7% |
| 2008 | 0.14x | CN¥34.89 Million | CN¥248.53 Million | ▼ -50.2% |
| 2007 | 0.28x | CN¥68.04 Million | CN¥241.37 Million | ▲ +431.1% |
| 2006 | -0.09x | CN¥-23.33 Million | CN¥274.10 Million | ▼ -160.2% |
| 2005 | 0.14x | CN¥55.96 Million | CN¥396.04 Million | ▲ +19.3% |
| 2004 | 0.12x | CN¥48.46 Million | CN¥409.06 Million | ▲ +306.6% |
| 2003 | -0.06x | CN¥-24.43 Million | CN¥426.00 Million | ▼ -127.0% |
| 2002 | 0.21x | CN¥94.30 Million | CN¥443.96 Million | ▲ +273.4% |
| 2001 | -0.12x | CN¥-51.00 Million | CN¥416.40 Million | ▼ -481.2% |
| 2000 | 0.03x | CN¥8.23 Million | CN¥256.24 Million | ▲ +177.3% |
| 1999 | -0.04x | CN¥-10.35 Million | CN¥249.06 Million | ▼ -244.8% |
| 1998 | 0.03x | CN¥3.89 Million | CN¥135.56 Million | — |